Skip to main content

 

Trilegal has advised India’s Eruditus Learning Solutions on its $150 million Series F fundraising round, led by TPG’s The Rise Fund, with participation from SoftBank Vision Fund 2, Leeds Illuminate, Accel, CPP Investments, Chan Zuckerberg Initiative, and certain individual investors. 

Eruditus offers education programs through classroom or online training in collaboration with top global universities and faculties. The company is accelerating its investments in technology to harness the power of generative AI to enrich the learner experience further and provide enhanced learning solutions. 

Eruditus’ funding round comes amid a mini-revival of edtech after the sector saw its most challenging period, with market leader Byju’s facing insolvency proceedings and rival Unacademy laying off over 250 employees. Things turned around earlier this year, with online coaching platform Physics Wallah raising $210 million in a Series B funding round, valuing the company at $2.8 billion.

The Trilegal team advising on the deal was led by corporate partners Amit Khansaheb and Pratyush Singh, and the team comprised of Bhavya Vatsa, Shaurya Jain and Neha Koppu.

 

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

AZB, Kirkland, Trilegal act on Bain Capital’s first India bet in 2025

by Nimitt Dixit |

AZB & Partners and Kirkland & Ellis have guided Bain Capital’s investment into Indian automotive component maker Dhoot Transmission Group, which was represented by Trilegal.

TT&A, SAM, Trilegal act on Quadria’s $100 mln investment in Aragen Life Sciences

by Nimitt Dixit |

Talwar Thakore & Associates advised Quadria Capital, a private equity fund focused on Asian healthcare, on its $100 million acquisition of a minority stake in Aragen Life Sciences. Shardul Amarchand Mangaldas & Co. represented Aragen in the transaction.

DMD, DSK act on IPO-bound OneSource’s $100 mln fundraise

by Nimitt Dixit |

DMD Advocates has advised HBM Healthcare Investments and other associated investors in leading OneSource Specialty Pharma’s $100 million fundraising through a pre-listing round, with DSK Legal representing OneSource on the deal.